Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04025060
Other study ID # NCR191271
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 10, 2019
Est. completion date May 31, 2021

Study information

Verified date May 2022
Source George Washington University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Lowering sugar-sweetened beverage (SSB) consumption is a central component of lifestyle behavior change aimed at preventing and managing obesity, yet effective reduction of SSB intakes has been met with many challenges. While their palatability, accessibility, publicity, affordability, and social acceptability contribute to frequent and sustained SSB consumption, their caffeine and sugar content may further encourage continued intake. Although adverse health consequences of excessive SSB consumption are well documented, the extent to which their pleasant taste (due primarily to their sugar content) and post-ingestive effects (due to their sugar and/or caffeine content) positively reinforce consumption among children has not been elucidated. The purpose of this study is to conduct a pilot intervention to examine the feasibility of removing caffeinated SSBs from the child diet and to explore whether caffeinated SSB removal induces withdrawal symptoms in 8-11 (3rd-5th grade) year old children. Participants will be randomly assigned to replace their usual caffeinated SSB consumption with either caffeinated SSBs, caffeine-free SSBs or sparkling water provided by the study team for two weeks.


Description:

Sugar-sweetened beverages (SSBs) significantly contribute to sugar and calorie intakes, and their consumption is associated with metabolic disease. Sweetened beverages also account for the majority of pediatric caffeine consumption. It is well-established that habitual caffeine use leads to dependence in adults and evidence for sugar dependence has been documented. However, caffeine and/or sugar dependence related to sweetened beverage consumption has not been evaluated, and determinants of their consumption among youth are severely understudied. It is critical to elucidate whether they may be physiologically or psychologically dependent on these beverages, particularly SSBs, which contain both caffeine and sugar. The purpose of this study is to conduct a pilot study where caffeinated SSB's are replaced with caffeinated SSBs provided by the study team (control) or with caffeine-free and unsweetened alternatives (also provided by the study team) for 2 weeks, among children who habitually consume caffeinated SSBs. Lowering SSB consumption is a central component of lifestyle behavior change aimed at preventing and managing obesity, yet effective reduction of SSB intakes has been met with many challenges. While their palatability, accessibility, publicity, affordability, and social acceptability contribute to frequent and sustained SSB consumption, their caffeine and sugar content may further encourage continued intake. Although adverse health consequences of excessive SSB consumption are well documented, the extent to which their pleasant taste (due primarily to their sugar content) and post-ingestive effects (due to their sugar and/or caffeine content) positively reinforce consumption among children has not been elucidated. This is particularly important to study among children from low-income and minority backgrounds, as these children have the highest rates of SSB intake and the highest prevalence of obesity. Specific Aims and Hypotheses: 1. Examine the feasibility of an intervention to remove caffeinated SSB from the child diet. We hypothesize that caffeinated SSB avoidance will be feasible among children, but that compliance will be lowest among those assigned to sparkling water, devoid of both caffeine and sugar. Compliance with beverage assignments will be assessed using daily online questionnaires and weekly dietary recalls. 2. Explore the extent to which caffeinated SSB removal induces withdrawal symptoms. We hypothesize that replacement of caffeinated SSBs with caffeine-free SSBs, or sparkling water will induce withdrawal symptoms compared to control (usual caffeinated SSB consumption). Participants will complete a child-adapted version of the validated Caffeine Withdrawal Symptoms Questionnaire (CWSQ) at baseline and daily (online) during the intervention.


Recruitment information / eligibility

Status Completed
Enrollment 29
Est. completion date May 31, 2021
Est. primary completion date May 31, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 8 Years to 11 Years
Eligibility Inclusion Criteria: - Reports regular consumption of caffeinated sugar-sweetened beverages, defined as consuming = 12 ounces of caffeinated SSB's per day Exclusion Criteria: - Poorly managed chronic medical condition; current or prior eating order diagnosis; asthma requiring medication in past three months; history of migraines; regular consumption (= 1 serving per week) of other caffeinated beverages, such as energy drinks, regular coffee, or hot tea

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Commercially-available caffeine-free soda
Subjects are asked to consume caffeine-free soda daily for two weeks
Carbonated water
Subjects are asked to consume unsweetened, carbonated water daily for two weeks
Regular soda
Subjects are asked to consume regular soda daily for two weeks

Locations

Country Name City State
United States Milken Institute School of Public Health and GW Medical Faculty Associates Washington District of Columbia

Sponsors (1)

Lead Sponsor Collaborator
George Washington University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Adherence Adherence will be assessed by summing the number of study beverages consumed each day over the course of the intervention. Two weeks
Primary Withdrawal Symptoms We will assess caffeine withdrawal symptoms using a child-adapted version of the validated caffeine withdrawal symptoms questionnaire (CWSQ). Participant responses to the CWSQ are on a Likert scale, where a score of "0" is not at all and "4" is "extremely" Average withdrawal scores over first 72 hours of intervention
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03994419 - PErioperAtive CHildhood ObesitY
Recruiting NCT06111040 - Nurturing Needs Study: Parenting Food Motivated Children N/A
Completed NCT03036696 - The BEACH Interview Study- Pregnant and Breastfeeding Mothers
Not yet recruiting NCT02484612 - Exercise Intensity and Appetite in Adolescents N/A
Completed NCT02959034 - Pediatric Metabolism and Microbiome Repository
Completed NCT02545764 - Training Induced Reduction of Lower-limb Joint Loads During Locomotion in Obese Children N/A
Recruiting NCT02426346 - A Scalable Weight Control Intervention for Adolescents Phase 2
Completed NCT02160847 - Development of the DRIVE Curriculum to Address Childhood Obesity Risk Factors N/A
Completed NCT01989065 - Healthy Lifestyles Program for You (HLP4U): Augmenting Childhood Obesity Treatment. N/A
Completed NCT02375490 - Healthy Start to Increase Physical Activity and Improve Healthy Eating in Early Childcare Centres N/A
Completed NCT01908153 - Taste Reward Processing in Pediatric Obesity
Completed NCT02343588 - A National School-based Health Lifestyles Interventions Among Chinese Children and Adolescents Against Obesity N/A
Completed NCT02074332 - Study on Obesity Intervention With Physical Exercise Among Students in Changping District, Beijing N/A
Completed NCT02086851 - Study of a Structured Parent Intervention on Adolescent Weight Loss Modification Program. N/A
Completed NCT01146314 - A Family Based Intervention to Reduce the Risk of Type 2 Diabetes in Children N/A
Terminated NCT00846521 - Study of Post-meal Blood Sugar Peaks in Association With Vascular Disease in Childhood Obesity Phase 4
Completed NCT04164277 - FirstStep2Health Intervention N/A
Withdrawn NCT04600648 - Sweet Taste Responsiveness in Relation to Insulin, Leptin and Adiposity Among Obese Treatment Seeking Children N/A
Completed NCT04395430 - A Novel School-clinic-community Online Model of Child Obesity Treatment in Singapore During COVID-19 N/A
Completed NCT03139877 - Pediatric Obesity Observational Prospective Trial